Elanco Animal Health Inc (ELAN) stock
ELANNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30129% above fair value
$25.85−0.56 (-2.12%)
Close on Nov 17, 2026Market cap $12.92BP/E –Yield –
Elanco Animal Health price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Elanco Animal Health's price to sales ratio was 2.6× on Nov 11, 2026, against 2.5× a year earlier. Over the last 5 years it ranged from 0.9× to 2.8×, with a median of 1.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.6× | +0.2 |
| 2025 | Dec 31, 2025 | 2.4× | +1.1 |
| 2024 | Dec 31, 2024 | 1.3× | −0.3 |
| 2023 | Dec 29, 2023 | 1.7× | +0.4 |
| 2022 | Dec 30, 2022 | 1.3× | −1.5 |
| 2021 | Dec 31, 2021 | 2.8× | −2.2 |
| 2020 | Dec 31, 2020 | 5.0× | +1.4 |
| 2019 | Dec 31, 2019 | 3.6× | −0.3 |
| 2018 | Dec 31, 2018 | 3.8× | – |
See a number that looks wrong?